4026 - 4050 of 6078 Results
Title
Year
- Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis2019OPENTitle: Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesisJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-08858-yBest OA location URL: https://www.nature.com/articles/s41467-019-08858-y.pdfCitation Count: 266
- M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder2019OPENTitle: M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress DisorderJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 989End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2019.02.020Best OA location URL: https://europepmc.org/articles/pmc6555658?pdf=renderCitation Count: 33
- Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's disease2019OPENTitle: Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 536End Page: 544Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27646Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27646Citation Count: 188
- Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration2019OPENTitle: Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 12Start Page: 5765End Page: 5774Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1814909116Best OA location URL: https://www.pnas.org/content/pnas/116/12/5765.full.pdfCitation Count: 98
-
OPENTitle: Predictive model of spread of Parkinson's pathology using network diffusionJournal Name: NeuroImagePublisher: Elsevier BVVol: 192Issue #:Start Page: 178End Page: 194Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuroimage.2019.03.001Best OA location URL: http://manuscript.elsevier.com/S1053811919301685/pdf/S1053811919301685.pdfCitation Count: 66
-
OPENTitle: Reduced habit-driven errors in Parkinson’s DiseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-39294-zBest OA location URL: https://www.nature.com/articles/s41598-019-39294-z.pdfCitation Count: 12
-
OPENTitle: Prioritizing Parkinson’s disease genes using population-scale transcriptomic dataJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-08912-9Best OA location URL: https://www.nature.com/articles/s41467-019-08912-9.pdfCitation Count: 153
- An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele2019OPENTitle: An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 alleleJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 127Issue #:Start Page: 278End Page: 286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2019.02.023Best OA location URL: https://europepmc.org/articles/pmc6588475?pdf=renderCitation Count: 26
- Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways2019OPENTitle: Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathwaysJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0675-9Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0675-9Citation Count: 16
-
OPENTitle: Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)Journal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 266Issue #: 5Start Page: 1203End Page: 1210Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-019-09250-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-019-09250-y.pdfCitation Count: 17
-
OPENTitle: Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 2Start Page: 301End Page: 313Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-191576Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191576?id=journal-of-parkinsons-disease%2Fjpd191576Citation Count: 114
- LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice2019OPENTitle: LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0679-5Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0679-5Citation Count: 44
- Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease2019OPENTitle: Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 5Start Page: 704End Page: 714Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25450Best OA location URL: https://doi.org/10.1002/ana.25450Citation Count: 132
- Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity2019OPENTitle: Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activityJournal Name: Molecular MetabolismPublisher: Elsevier BVVol: 24Issue #:Start Page: 120End Page: 138Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.molmet.2019.02.005Best OA location URL: https://doi.org/10.1016/j.molmet.2019.02.005Citation Count: 11
-
OPENTitle: The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 163End Page: 169Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.027Best OA location URL: http://spiral.imperial.ac.uk/bitstream/10044/1/68972/2/WilsonPolitis_PDE4_SleepPD_RevisedText_Clean.pdfCitation Count: 15
-
OPENTitle: Network abnormalities among non‐manifesting Parkinson disease related LRRK2 mutation carriersJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 8Start Page: 2546End Page: 2555Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.24543Best OA location URL: https://europepmc.org/articles/pmc6865680?pdf=renderCitation Count: 21
-
OPENTitle: SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 526End Page: 535Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27642Best OA location URL: https://europepmc.org/articles/pmc6469643?pdf=renderCitation Count: 101
- High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra2019OPENTitle: High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia NigraJournal Name: RadiologyPublisher: Radiological Society of North America (RSNA)Vol: 291Issue #: 1Start Page: 149End Page: 157Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1148/radiol.2019181042Best OA location URL: https://europepmc.org/articles/pmc6438360?pdf=renderCitation Count: 44
- Awake Testing during Deep Brain Stimulation Surgery Predicts Postoperative Stimulation Side Effect Thresholds2019OPENTitle: Awake Testing during Deep Brain Stimulation Surgery Predicts Postoperative Stimulation Side Effect ThresholdsJournal Name: Brain SciencesPublisher: MDPI AGVol: 9Issue #: 2Start Page: 44End Page: 44Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci9020044Best OA location URL: https://www.mdpi.com/2076-3425/9/2/44/pdf?version=1550479268Citation Count: 13
-
OPENTitle: Progressive brain atrophy in chronically infected and treated HIV+ individualsJournal Name: Journal of NeuroVirologyPublisher: Springer Science and Business Media LLCVol: 25Issue #: 3Start Page: 342End Page: 353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13365-019-00723-4Best OA location URL: https://europepmc.org/articles/pmc6635004?pdf=renderCitation Count: 35
- OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trial2019OPENTitle: OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 174End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.009Best OA location URL: https://zenodo.org/records/3832127/files/R1-OnabotulinumtoxinA_and_Cognitive_Behavioral_Therapy_in_Functional_Dystonia_A_Pilot_Randomized_Clinical_Trial_pdf.io.pdfCitation Count: 15
- Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson’s disease2019OPENTitle: Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 2Start Page: e0211699End Page: e0211699Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0211699Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0211699&type=printableCitation Count: 9
- Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's disease2019OPENTitle: Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 3End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.001Best OA location URL: http://manuscript.elsevier.com/S135380201930032X/pdf/S135380201930032X.pdfCitation Count: 23
-
OPENTitle: Neural correlates of distinct cognitive phenotypes in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 399Issue #:Start Page: 22End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.02.013Best OA location URL: https://europepmc.org/articles/pmc6436969?pdf=renderCitation Count: 10
- Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD2019OPENTitle: Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 879End Page: 899Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-019-01962-9Best OA location URL: https://europepmc.org/articles/pmc6533145?pdf=renderCitation Count: 102